NUS logo

NU SKIN ENTERPRISES INC - A

NUSNYSE
πŸ† #3636 by market capUS Equity
$472.08β–Ό $16.95 (βˆ’3.59%)
Simulated price
πŸ””
Track NUS
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 3.6%
7dβ–² 9593.6%
14dβ–² 9838.5%
30dβ–² 9653.7%
ytdβ–² 4807.3%
1yβ–² 3807.9%
🏦Market Cap
$226M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-15.4%
Declining
πŸ“ŠGross Margin
69.2%
High
πŸ’΅FCF Margin
2.1%
Thin
βš–οΈP/S Ratio
0.2x
Cheap
Otter Score
80
Good

Trading Snapshot

Day Range
$470.52 – $479.91
52-Week Range
$4.49 – $12.59
Volume
$2.61B
Avg Volume
$3.07B
Shares Outstanding
48.5M
Next Earnings
Oct 29, 2026

Fundamentals Snapshot

Annual Revenue
$1.49B
Last Q Revenue
$320M
P/E Ratio
β€”
P/S Ratio
0.2x
EPS (TTM)
$-4.48
Dividend Yield
5.13%
Dilution (1yr)
+0.4%

Why Investors Own NUS

  • βœ“High-growth profile β€” revenue up +40.5% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 48% gross margin and 8% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

NUS logo

NU SKIN ENTERPRISES INC - A

NUS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$1.5Bβ–Ό βˆ’14.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
69.4%β–² +1.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$91Mβ–Ό βˆ’160.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$46Mβ–Ό βˆ’34.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
49.9Mβ–² +0.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$126Mβ–² +$166M YoY
StockOtter Β· stockotter.space

About NU SKIN ENTERPRISES INC - A

Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other related weight management aids. The organization also significantly invests in research and development, particularly for its skincare and nutritional supplement portfolios. Nu Skin operates a network of retail stores and customer service centers exclusively within Mainland China. Its extensive product lines are marketed under its proprietary brands, which include Nu Skin, Pharmanex, and ageLOC. These products reach consumers through multiple sales channels, including direct-to-consumer interactions, an extensive network of independent distributors, and its dedicated e-commerce platform. Nu Skin Enterprises, Inc. was established in 1984 and maintains its corporate headquarters in Provo, Utah.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Good
80/100

Analyst Price Target

β“˜
Average Target
$563.75
β–² +19.4% Upside
High Target$677.10
Low Target$496.18
Based on 29 analysts

Latest News & Updates